Replay available

Alignment Healthcare, Inc. (ALHC) Q1 2025 Earnings Call

Alignment Healthcare, Inc. (NASDAQ: ALHC) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.

Thu, May 1, 2025 at 5:00 PMendedReplay
Alignment Healthcare, Inc. (ALHC) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jonathan Young

Analyst, UVS

Jessica Tassin

Analyst, Piper Sandler

Whit Mayo

Analyst, Lyric Partners

John Kao

Founder and CEO

Thomas Freeman

Chief Financial Officer

Joanna Gajuk

Analyst, Bank of America

Ryan Daniels

Analyst, William Blair

Ryan Langston

Analyst, TD Cowen

John Ransom

Analyst, Raymond James

Michael Ha

Analyst, Bayard

Andrew Mock

Analyst, Barclays

Matthew Gilmore

Analyst, KeyBank

Replay transcript excerpt

Good afternoon and welcome to Alignment Healthcare's first quarter 2025 earnings conference call and webcast. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand has been raised. To withdraw your question, please press star 1 1 again. Please note that this event is being recorded. Leading today's call are John Kao, Founder and CEO, and Thomas Freeman, Chief Financial Officer. Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions, and information currently available to us. Descriptions of some of the factors that could cause actual results that differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the risk factors section of our annual report on Form 10-K for the fiscal year ended December 31st, 2024. Although we believe our expectations are reasonable, we undertake no obligation to revise any statements to reflect changes that occur after this call. In addition, please note that the company will be discussing certain non-GAAP financial measures that they believe are important in evaluating performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliation of historical non-GAAP financial measures can be found in the press release tha...

More from Alignment Healthcare, Inc.